Medivir appoints Dr. Linda Basse as Chief Medical OfficerRead more
Investigator-initiated phase II clinical study of remetinostat started in patients with basal cell carcinomaRead more
MIV-711 osteoarthritis phase IIa extension study outcomes show continuing positive effect on joint structureRead more
Quarterly report presentations
Medivir Corporate Governance documention.
Documentation from Medivir's Annual General Meetings.